Clinical study to examine the efficacy of the intravitreal injection of anti-VEGF antibody (Avastin) for intraocular neovascular disease and macular edema
Not Applicable
- Conditions
- Ophthalmic neovascular disease Diabetic retinopathy Retinal vein occlusion
- Registration Number
- JPRN-UMIN000014338
- Lead Sponsor
- Department of Ophthalmology and Visual Science, Chiba University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Not provided
Exclusion Criteria
1) The patient who has difficulty in observation of the fundus for high cataract, corneal clouding 2) Patient younger than 20 years 3) The patient who received other study medication or other clinical experimental medicine within three months before this medication start 4) In addition, the patient who judged an examination responsibility (allotment) doctor to be inappropriate as a subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Ocular fundus
- Secondary Outcome Measures
Name Time Method Visual acuity Optical coherence tomography Fluorescein angiography Improvement of visual field Improvement of intraocular pressure